Get the Stockscreener App
1.675
10.19%
-0.19
Pre-market:
1.74
0.065
+3.88%
Agenus Inc Stock (AGEN) Latest News
Equities Analysts Offer Predictions for Agenus Q1 Earnings - Defense World
HC Wainwright Reaffirms Neutral Rating for Agenus (NASDAQ:AGEN) - Defense World
Agenus stock falls after revenue miss - MSN
Agenus (AGEN) Q4 2024 Earnings Call Transcript - AOL
Agenus stock hits 52-week low at $1.91 amid market challenges - Investing.com Australia
Agenus Inc. Earnings Call: Mixed Sentiments and Strategic Focus - TipRanks
Agenus stock hits 52-week low at $1.91 amid market challenges By Investing.com - Investing.com South Africa
Agenus Inc. (NASDAQ:AGEN) Q4 2024 Earnings Call Transcript - MSN
Agenus’ Strategic Cost Reductions and CRC Focus Lead to Hold Rating - TipRanks
Agenus Inc (AGEN) Q4 2024 Earnings Call Highlights: Strategic Moves Amid Financial Challenges - Yahoo Finance
Agenus Inc (AGEN) Q4 2024 Earnings Call Highlights: Strategic Mo - GuruFocus.com
Agenus Inc. Reports Strategic Cost Reductions and BOT/BAL Progress - TipRanks
Agenus: Q4 Earnings Snapshot - mySA
Agenus stock falls as Q4 revenue drops sharply By Investing.com - Investing.com South Africa
Earnings call transcript: Agenus sees stock jump in Q4 2024 - Investing.com India
Earnings call transcript: Agenus sees stock jump in Q4 2024 By Investing.com - Investing.com UK
Agenus Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Agenus: Q4 Earnings Snapshot -March 11, 2025 at 07:44 am EDT - Marketscreener.com
Agenus to lower annual burn to about $50 mln by mid-2025 -March 11, 2025 at 07:40 am EDT - Marketscreener.com
Agenus Slashes Cash Burn by 50% While Advancing Promising Cancer Drug Program - StockTitan
Agenus Reports Q4 and Year-End 2024 Results; Strategic Operational Improvements and Significant Cost Reductions Enhance Sustainability of Promising BOT/BAL Program - Bluefield Daily Telegraph
Earnings Scheduled For March 11, 2025 - Benzinga
Class Action Filed Against Agenus Inc. (AGEN) Seeking Recovery for InvestorsContact Levi & Korsinsky - ACCESS Newswire
Contrasting Agenus (NASDAQ:AGEN) and Cortexyme (NASDAQ:CRTX) - Defense World
Agenus (AGEN) Projected to Post Earnings on Tuesday - Defense World
Agenus Inc. to Host Earnings Call - ACCESS Newswire
Agenus stock touches 52-week low at $2.48 amid market challenges - Investing.com Australia
Agenus stock touches 52-week low at $2.48 amid market challenges By Investing.com - Investing.com South Africa
Agenus reports promising sarcoma study results - MSN
AGEN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Agenus Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Shareholders that lost money on Agenus Inc.(AGEN) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Levi & Korsinsky Notifies Agenus Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineAGEN - ACCESS Newswire
AGEN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Agenus Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
AGEN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Agenus Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Shareholders That Lost Money on Agenus Inc. (AGEN) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire
Investors who lost money on Agenus Inc.(AGEN) should contact Levi & Korsinsky about pending Class ActionAGEN - ACCESS Newswire
Agenus, Inc. to Host Earnings Call - ACCESS Newswire
Agenus Inc. revises financial agreements, extends warrant terms - Investing.com India
Agenus Inc. revises financial agreements, extends warrant terms By Investing.com - Investing.com South Africa
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Agenus - ACCESS Newswire
Levi & Korsinsky Reminds Agenus Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 5, 2024AGEN - ACCESS Newswire
Agenus Reports Impact of Key Immuno-Oncology Data Presented at Leading Medical Conferences and Peer-Reviewed Publications - Business Wire
Can Agenus Breakthrough in Colorectal Cancer? CCO to Reveal Strategy at Major Oncology Conference - StockTitan
When Will Agenus Reveal Its 2024 Performance? Key Date for Biotech Investors - StockTitan
Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2024 Financial Report - Business Wire
Agenus Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before November 5, 2024 to Discuss Your RightsAGEN - ACCESS Newswire
Can This Novel Triple Immunotherapy Crack the Code for Treatment-Resistant Gastric Cancer? - StockTitan
1.39%
0.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):